TRIS Rating Affirms Company and Issue Ratings of “BGH” at “A” with “Stable” Outlook

General News Wednesday April 28, 2010 07:13 —TRIS News Release

TRIS Rating Co., Ltd. has affirmed the company and issue ratings of Bangkok Dusit Medical Services PLC (BGH) at “A” with “stable” outlook. The ratings reflect BGH’s leading position as the largest private hospital operator in Thailand, sustained patient volume growth, capable physicians and experienced management team, and high quality service. The ratings also take into consideration BGH’s strong franchise network under the Bangkok Hospital, Samitivej Hospital, and BNH Hospital brands. These strengths are partially offset by concerns over the number of foreign patients that might be dropped amid prolonged political instability, the relatively low returns on permanent capital, and concerns over leverage levels in the future if the company continues to fund its expansions through debt financing.

The “stable” outlook is based on the expectation that BGH will sustain its operating performance at the current level. Future investments or acquisitions, if any, should be funded largely through operating cash flow to keep the total debt to capitalization ratio below 50%.

TRIS Rating reported that BGH was established in 1969 with initial registered capital of Bt10 million to operate a private hospital, Bangkok Hospital. Currently, 18 hospitals, with a total of 3,032 registered beds, are under the umbrella of BGH. Twelve hospitals are operated under the Bangkok Hospital brand, three hospitals under the Samitivej Hospital brand, one hospital under the BNH Hospital brand, and two international hospitals under the Royal International Hospital brand. During the past three years, 55% of patient revenue came from inpatients; the remainder came from outpatients. In 2009, BGH achieved Joint Commission International (JCI) accreditation for three hospitals: BNH Hospital, Bangkok Phuket Hospital, and Bangkok Pattaya Hospital. Previously, six hospitals under BGH have received JCI accreditation: Bangkok Hospital, Bangkok Heart Hospital, Wattanosoth Hospital (cancer), Samitivej Sukhumvit Hospital, Samitivej Srinakarin Hospital and Samititvej Sriracha Hospital.

TRIS Rating said, BGH grew dramatically during 2004-2008, mostly through acquisition of existing hospitals in the industry. BGH acquired Samitivej PLC, BNH Medical Centre Co., Ltd., and several hospitals in the eastern, southern, and northeastern regions of Thailand, including Bangkok Pattaya Hospital Co., Ltd., Bangkok Rayong Hospital Co., Ltd., Bangkok Phuket Hospital Co., Ltd., Bangkok Hadyai Hospital Co., Ltd., and Bangkok Ratchasima Hospital Co., Ltd. In addition, the company invested in two new hospitals in Cambodia. Revenue from hospital operations grew at a compound annual growth rate (CAGR) of 42% during 2004-2008. The CAGR of outpatient visits per day was 31% and CAGR of the admission rate per day was 29% during the same period. However, due to the impact from political instability and the global financial crisis, patient services revenue in 2009 grew by 1.93%. Outpatient revenues grew by 2.73%, while inpatient revenues dropped slightly by 1.23%. The decline in inpatient revenues was mainly due to the declining number of foreign patients together with discounts and promotional packages, even though admissions of local patients grew by 6.5%. The revenue per outpatient visit in 2009 stayed almost the same as the prior year, while the revenue per inpatient day dropped by 3.05%. The average length of stay declined slightly from 3.05 days in 2008 to 2.95 days in 2009. In terms of contribution, the revenue contribution from international patients was maintained at 35%-36% of total patient revenue over the past three years.

The acquisitions of several hospitals in the past few years pushed BGH’s debt to capitalization ratio to peak at 54.5% in 2006. However, cash flow from operations improved and capital expenditures fell during 2008-2009. Thus, BGH’s capital structure has gradually improved since there was no major acquisition last year. The debt to capitalization ratio at the end of 2009 stood at 45.39%. The earnings before interest, tax, depreciation and amortization (EBITDA) interest coverage ratio also increased, rising from 7.6 times in 2006 to 8.19 times in 2009. Most debts are denominated in Thai baht with fixed interest rates. The company has very low exposure to interest rate risk or foreign exchange risk. BGH plans to open a hospital with 60 beds in Hua Hin in 2011, while the investment in a new hospital in Phnom Pehn is delayed due to several unfavorable factors. In addition, the company has acquired land to build a new hospital in Khao Yai. These projects are mostly financed through operating cash flow.

The profitability of BGH is relatively stable and comparable with its peers. Operating income as a percentage of sales sustained at 22%-22.5% during 2006-2009. Going forward, BGH is challenged to continually improve its cost structure. The profitability of the company will depend on its ability to control cost and improve the utilization of shared assets and services within the group. The company’s relatively large asset size is not fully utilized, keeping the pretax return on permanent capital lower than peers, said TRIS Rating. -- End

Bangkok Dusit Medical Services PLC (BGH)
Company Rating:                                          Affirmed at A
Issue Ratings:
BGH113A: Bt3,000 million senior debentures due 2011      Affirmed at A
BGH133A: Bt2,000 million senior debentures due 2013 	Affirmed at A
BGH146A: Bt2,000 million senior debentures due 2014	Affirmed at A
BGH166A: Bt1,000 million senior debentures due 2016  	Affirmed at A
Rating Outlook:	                                   Stable
Copyright 2010, TRIS Rating Co., Ltd.  All rights reserved.  Any unauthorized use, disclosure, copying, republication, further transmission, dissemination, redistribution or storing for subsequent use for any purpose, in whole or in part, in any form or manner or by any means whatsoever, by any person, of the credit rating reports or information is prohibited.  The credit rating is not a  statement of fact or a recommendation to buy, sell or hold any debt instruments.  It is an expression of opinion regarding credit risks for that instrument or particular company. The opinion expressed in the credit rating does not represent investment or other advice and should therefore not be construed as such. Any rating and information contained in any report written or published by TRIS Rating has been prepared without taking into account any recipient’s particular financial needs, circumstances, knowledge and objectives.  Therefore, a recipient should assess the appropriateness of such information before making an investment decision based on this information. Information used for the rating has been obtained by TRIS Rating from the company and other sources believed to be reliable. Therefore, TRIS Rating does not guarantee the accuracy, adequacy, or completeness of any such information and will accept no liability for any loss or damage arising from any inaccuracy, inadequacy or incompleteness. Also, TRIS Rating is not responsible for any errors or omissions, the result obtained from, or any actions taken in reliance upon such information.

เว็บไซต์นี้มีการใช้งานคุกกี้ ศึกษารายละเอียดเพิ่มเติมได้ที่ นโยบายความเป็นส่วนตัว และ ข้อตกลงการใช้บริการ รับทราบ